Microscopic Studies on Skeletal Muscle in Gout Patients Treated with Allopurinol

R. W. E. Watts, J. T. Scott, R. A. Chalmers, Lucille Bitensky, J. Chayen

QJM · 1971 · 32 citations · 0 references

Concepts

Abstract

Crystals of hypoxanthine and xanthine and of oxipurinol (a metabolite of allopurinol) have been found in skeletal muscle biopsies from gout patients who are being treated with the xanthine oxidase inhibitor, allopurinol. These patients have no clinical manifestations of muscle disease. Biopsies from normal control subjects contained no more than two hypoxanthine crystals per standard size section, and no other crystals. Untreated gout patients' biopsies usually contained crystals of one or more of the following: anhydrous uric acid, uric acid dihydrate, sodium urate monohydrate, and no other crystals. The crystals were identified by: their size and shape, their extinction angle, their sign of birefringence, their refractive index, and the degree of asymmetry of the birefringence which was measured by positive and negative compensation in media of different refractive index. The latter method is described in the Appendix to this paper. The implications of these results for the treatment of gout, their relationship to the findings in congenital xanthine oxidase deficiency (xanthinuria) and the possible metabolic origin of the crystals are discussed.